Vx-702 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±1.5 mmHg at 25℃ |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.629 |
| B pt. | 555.2±60.0 ℃ at 760 mmHg |
| Density | 1.503g/cm3 |
Safety Information
| Hazard Statement(s) | H315-H319 |
| Precautionary Statement | P264-P280-P302 + P352-P337 + P313-P305 + P351 + P338-P362 + P364-P332 + P313 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 289.6±32.9℃ |
| Storage Temp. | '20℃ |
| Packaging | Glass Bottle |
Description
Recommended products
Glycidyl Stearate 96.0%
Application
VX-702 is a p38 mitogen-activated protein kinase (MAPK) inhibitor. VX-702 had no effect on platelet aggregation induced by any of the p38 MAPK agonists. VX-702 has potential use in the treatment of inflammation rheumatoid arthritis and cardiovascular diseases.
Purpose
For R&D use onlynot for drug household or other uses.
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |